Today, from “mind control” in science fiction movies to medical rehabilitation, industrial manufacturing and virtual reality in reality, brain-computer interface technology (BCI) is accelerating from the laboratory to industrialization, setting off a technological revolution sweeping the world.
Brain-computer interface development is accelerating
Brain-computer interface technology is mainly divided into non-invasive and invasive types. Invasive brain-computer interface technology has been applied in clinical practice, which can significantly improve the accuracy of “brain cancer” surgery; non-invasive brain-computer interface technology has also been integrated into some communities, bringing new solutions for early screening and diagnosis of diseases such as Alzheimer’s disease and stroke.
In the view of industry insiders, brain-computer interface technology may be combined with the spinal cord in the future to allow patients with high paraplegia to stand up again; by simulating the function of the eyes, the blind can regain their sight; by regulating the hippocampus, memory can be strengthened; combined with embodied intelligence, artificial intelligence can give birth to consciousness.
Last month, Musk demonstrated the form of future consumer-grade brain-computer interfaces at a Neuralink conference – the human brain will be fully integrated with AI to achieve interconnection at the consciousness level. At present, Neuralink has 7 subjects, including 4 spinal cord injury patients and 3 amyotrophic lateral sclerosis (ALS) patients. Musk boldly predicted that this goal will be achieved in 2028.
WiMi drives the leap of new quality productivity
At the same time, data shows that Wimi Hologram Cloud Inc (WIMI), a brain-computer interface concept stock, lists brain-computer interface as the direction of new quality productivity, focusing on non-invasive and invasive brain-computer interface technology, and developing brain-controlled robot technology based on steady-state visual evoked potential (SSVEP), which allows operators to control collaborative robots through EEG signals to complete assembly tasks, improve the efficiency of human-computer interaction, and provide new ideas and methods for industry development.
Shanghai Breakthrough: In July 2025, researchers in Shanghai enabled participants to “speak with their minds” using BCIs, offering hope for patients with speech loss due to ALS or stroke. This system decodes neural signals into computer-generated speech, marking a clinical-stage milestone.
Impact: These advancements are critical for “locked-in” patients, providing a lifeline for communication where traditional methods fail.
In addition, in order to accumulate the potential for industrial development, WiMi focuses on commercialization and cross-industry integration. In the penetration of multiple fields, it improves the implementation of brain-computer interface + new ecology in multiple scenarios, accelerates the combination of quantum computing and brain science, and further explores the use of quantum computing to decode brain signals in real time. This will not only help cultivate the upstream and downstream industrial chain ecology, but also promote the deep integration of brain-computer interface and AI technology in the future, promote the large-scale commercial use of technology, lay the foundation for efficient human-computer interaction, and accelerate the transformation of innovation into industrial momentum.
Conclusion
When the spotlight of science and technology is on the Eastern and Western hemispheres at the same time, brain-computer interface is no longer a concept in science fiction, but a real technology that is rewriting the possibility of human life. Since the beginning of this year, it can be clearly seen that the entire brain-computer interface industry gives people the feeling that clinical progress is accelerating and a hundred flowers are blooming, especially in clinical trials. All parties are striving towards their own goals, aiming to pave the way for clinical applications after the technology matures in the future.
BCI research has made remarkable strides, particularly in restoring communication and motor function for patients with neurological disorders like ALS and SCI. Non-invasive technologies are improving accessibility, while invasive BCIs offer high precision for severe cases. Clinical trials by Neuralink, Synchron, and others signal a move toward commercialization, but challenges like signal quality, ethics, and cybersecurity must be addressed. The integration of AI and novel signals like tissue deformation opens exciting possibilities, potentially revolutionizing healthcare, gaming, and human-machine interaction.
